Autoimmune Disease
+7
May 29, 2026
•
6 min read
An in-depth audit of neuropsychiatric lupus (NPSLE) diagnostic gaps and lupus nephritis trial updates, including the latest 2026 FDA pipeline reviews.
+6
May 5, 2026
7 min read
Explore the May 2026 lupus landscape, featuring the newly approved Saphnelo Pen (anifrolumab SC), Gazyva (obinutuzumab) success, and the latest in CAR-T cell therapy for SLE.
+9
Apr 16, 2026
4 min read
Lupus. Celiac. Arthritis. Myositis. IBD. Behçet's. May is about to bring lots of awareness.
